search
Back to results

Comparative Effectiveness of IIMR Versus CDSMP

Primary Purpose

Mental Illness, Chronic Disease

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Integrated Illness Management and Recovery
Chronic Disease Self-Management Program
Sponsored by
Dartmouth-Hitchcock Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Mental Illness focused on measuring integrated health, mental health, illness management, cardiovascular disease, physical health

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Serious Mental Illness (diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or chronic depression with moderate impairment in functioning) receiving services at Centerstone(KY and TN)
  • Diagnosis of a chronic medical condition increasing risk of early mortality from cardiovascular or respiratory disease (e.g., diabetes, hyperlipidemia, hypertension, COPD, heart failure, tobacco dependence, obesity), and at least 1 ER visit or hospitalization within the past year or judgment by the treatment team of substantial need for illness self-management training.

Exclusion Criteria:

  • Consumers who do not speak English
  • Consumers with either no, or a well-controlled medical condition will not be included
  • Individuals residing in a nursing home or other institution
  • Evidence of significant cognitive impairment as indicated by a Mini Mental Status Examination score <24, will be excluded

Eligibility for the COVID -related substudy is dependent on enrollment and participation in the parent project.

Sites / Locations

  • Seven Counties ServicesRecruiting
  • CenterstoneRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Integrated Illness Management and Recovery (I-IMR):

Stanford Chronic Disease Self-Management Program (CDSMP):

Arm Description

Participants assigned to I-IMR will receive 2 individual sessions to discuss principles of recovery and set personally meaningful goals, with the remainder of the 14 I-IMR sessions delivered in groups of 8-10 (to enable individual tailoring)

Participants randomly assigned get a 6-session group-based educational program co-delivered by two peers (lay people who have successfully managed a chronic illness) or a peer and a professional

Outcomes

Primary Outcome Measures

Change in Knowledge and skills in illness self-management using the Illness Management and Recovery Scale
Change in knowledge and skills for illness self-management. Range of scores from 15-75 with higher scores meaning better illness self-management.
Change in Patient Activation on the Patient Activation Measure (PAM)
Change in Patient Activation (engagement in health care). Maximum score of 100, higher scores meaning greater activation.
Change in Acute Hospital Events from Electronic Medical Record Review.
Change in the number of acute hospital events. At each assessment a combination of participant report and verified information from mental health clinics will be used to validate the number acute hospital events.
Knowledge and Behaviors for Preventing Catching and Spreading COVID-19 Scale
Change in score on this measure, which was developed as part of the study plan because no suitable scale existed to assess knowledge and safety behaviors for COVID-19. Scores range from 0-100%, with higher scores indicating greater knowledge and enactment of safety behaviors.

Secondary Outcome Measures

Full Information

First Posted
May 1, 2019
Last Updated
February 13, 2023
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
Patient-Centered Outcomes Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT03966872
Brief Title
Comparative Effectiveness of IIMR Versus CDSMP
Official Title
Comparative Effectiveness of Integrated Illness Management and Recovery Versus the Chronic Disease Self-Management Program
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 2, 2019 (Actual)
Primary Completion Date
January 2024 (Anticipated)
Study Completion Date
March 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
Patient-Centered Outcomes Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study will enroll 600 people with serious mental illness who receive services at Centerstone in KY or TN and will compare two different evidence-based self-management interventions: Integrated Illness Management and Recovery (I-IMR), a program developed by the study team at Dartmouth that trains people with serious mental illness on physical and mental health self-management, and the Stanford Chronic Disease Self-Management Program (CDSMP), a program largely focused on physical health self-management that has been used widely in the general population.
Detailed Description
The proposed study will be the first to compare two commonly used but substantially different, evidence-based self-management interventions. Integrated Illness Management and Recovery (I-IMR), is an individually-tailored, 16-session, integrated program combining both physical and mental health self-management specifically developed for people with SMI. In contrast, the Stanford Chronic Disease Self-Management Program (CDSMP) is a group-based, 6-session, chronic disease self-management program largely focused on physical health self-management alone. I-IMR is delivered by community mental health providers or by community outreach workers, while CDSMP is co-delivered by two peers or by a health professional and a peer. Both programs have been widely recommended, disseminated, and used. The proposed parent study will randomize people with serious mental illness to I-IMR (n=300) and CDSMP (n=300).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mental Illness, Chronic Disease
Keywords
integrated health, mental health, illness management, cardiovascular disease, physical health

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Integrated Illness Management and Recovery (I-IMR):
Arm Type
Experimental
Arm Description
Participants assigned to I-IMR will receive 2 individual sessions to discuss principles of recovery and set personally meaningful goals, with the remainder of the 14 I-IMR sessions delivered in groups of 8-10 (to enable individual tailoring)
Arm Title
Stanford Chronic Disease Self-Management Program (CDSMP):
Arm Type
Experimental
Arm Description
Participants randomly assigned get a 6-session group-based educational program co-delivered by two peers (lay people who have successfully managed a chronic illness) or a peer and a professional
Intervention Type
Behavioral
Intervention Name(s)
Integrated Illness Management and Recovery
Intervention Description
Education and skills training groups on illness management of chronic medical and psychiatric illness.
Intervention Type
Behavioral
Intervention Name(s)
Chronic Disease Self-Management Program
Intervention Description
Education and skills training groups on illness management of chronic conditions
Primary Outcome Measure Information:
Title
Change in Knowledge and skills in illness self-management using the Illness Management and Recovery Scale
Description
Change in knowledge and skills for illness self-management. Range of scores from 15-75 with higher scores meaning better illness self-management.
Time Frame
Change from Baseline to 12 months
Title
Change in Patient Activation on the Patient Activation Measure (PAM)
Description
Change in Patient Activation (engagement in health care). Maximum score of 100, higher scores meaning greater activation.
Time Frame
Change from Baseline to 12 months
Title
Change in Acute Hospital Events from Electronic Medical Record Review.
Description
Change in the number of acute hospital events. At each assessment a combination of participant report and verified information from mental health clinics will be used to validate the number acute hospital events.
Time Frame
Change from Baseline to 12 months
Title
Knowledge and Behaviors for Preventing Catching and Spreading COVID-19 Scale
Description
Change in score on this measure, which was developed as part of the study plan because no suitable scale existed to assess knowledge and safety behaviors for COVID-19. Scores range from 0-100%, with higher scores indicating greater knowledge and enactment of safety behaviors.
Time Frame
Change from Baseline to 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Serious Mental Illness (diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or chronic depression with moderate impairment in functioning) receiving services at Centerstone(KY and TN) Diagnosis of a chronic medical condition increasing risk of early mortality from cardiovascular or respiratory disease (e.g., diabetes, hyperlipidemia, hypertension, COPD, heart failure, tobacco dependence, obesity), and at least 1 ER visit or hospitalization within the past year or judgment by the treatment team of substantial need for illness self-management training. Exclusion Criteria: Consumers who do not speak English Consumers with either no, or a well-controlled medical condition will not be included Individuals residing in a nursing home or other institution Evidence of significant cognitive impairment as indicated by a Mini Mental Status Examination score <24, will be excluded Eligibility for the COVID -related substudy is dependent on enrollment and participation in the parent project.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Skyla Marceau
Phone
603-229-5412
Email
skyla.marceau@dartmouth.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Meghan Santos
Phone
603-229-5413
Email
Meghan.Santos@Dartmouth.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sarah Pratt
Organizational Affiliation
Dartmouth-Hitchcock Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Seven Counties Services
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40220
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Theresa Watson, RN, MS, CPHQ
Phone
502-436-5696
Facility Name
Centerstone
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37228
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mandi Ryan
Phone
615-574-1195

12. IPD Sharing Statement

Learn more about this trial

Comparative Effectiveness of IIMR Versus CDSMP

We'll reach out to this number within 24 hrs